Oncology News | pharmaphorum

News

Groundbreaking lung cancer approval a big boost for AZ's Imf...

AstraZeneca’s immunotherapy Imfinzi has gained US approval in an important new earlier treatment setting for lung cancer patients.

News

Roche to buy health records firm Flatiron for $1.9bn

Flatiron has backers including Google parent Alphabet

News

NICE recommends funding for three thyroid cancer drugs

Eisai's drug finally funded after two year delay

News

J&J gets quick approval for new next-gen prostate cancer dru...

The FDA has approved Johnson & Johnson’s next generation prostate cancer drug, apalutamide in an early but tough to treat form of prostate cancer that has not spread.

News

BMS makes record $1.8bn bet on Nektar cancer drug

Bristol-Myers Squibb scored a first-in-class approval with cancer immunotherapy Opdivo just a few years ago – could it be about repeat the trick with a new drug that stimulates natural kill

News